Superluminal Medicines is a generative biology and chemistry company focused on accelerating drug discovery and development. Their Hyperloop™ platform integrates structure-based drug discovery with machine learning. The company has raised significant venture capital, including a $120 million funding round led by RA Capital Management, and is based in Boston, MA. The website and news articles confirm their active operations and scientific focus.
Filed May 5, 2026 · Manhattan, NY
Your competitors in Manhattan are getting unlimited new business leads.
SUPERLUMINAL MEDICINES, INC. is a biotechnology business (Corp) registered on May 5, 2026 with the New York Division of Corporations. The business is located in Manhattan, New York.
Get owner name, phone, email, and website for newly registered businesses delivered to your inbox daily.
Start Your Free Trial ›Filing timeline will be available soon.
SUPERLUMINAL MEDICINES, INC. was registered as Corp on May 5, 2026 in New York.
SUPERLUMINAL MEDICINES, INC.'s principal address on file is Manhattan, NY, 10005.
SUPERLUMINAL MEDICINES, INC. is classified as a biotechnology business (drug discovery).
No EIN was found on file for SUPERLUMINAL MEDICINES, INC. at the time of registration.
Based on the business category, these service providers typically target this type of business.